GOLDMAN SACHS GROUP INC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 4 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$28,000
-56.9%
44,880
-42.3%
0.00%
Q3 2019$65,000
-72.5%
77,784
-77.8%
0.00%
Q2 2019$236,000
+926.1%
350,572
+1148.1%
0.00%
Q1 2019$23,000
-82.4%
28,088
-65.6%
0.00%
Q4 2018$131,000
-43.3%
81,636
+17.3%
0.00%
Q3 2018$231,000
+425.0%
69,616
+253.6%
0.00%
Q2 2018$44,000
-98.1%
19,685
-97.5%
0.00%
-100.0%
Q1 2018$2,269,000
+237.6%
782,330
+224.7%
0.00%
Q4 2017$672,000
+2140.0%
240,935
+1654.6%
0.00%
Q2 2017$30,000
+100.0%
13,732
-18.9%
0.00%
Q3 2016$15,000
-44.4%
16,931
-22.7%
0.00%
Q4 2015$27,000
-70.3%
21,895
-70.9%
0.00%
Q3 2015$91,000
-24.2%
75,153
+8.9%
0.00%
Q2 2015$120,000
-55.9%
68,986
-63.3%
0.00%
Q1 2015$272,000
+134.5%
187,837
+35.9%
0.00%
Q4 2014$116,000
-46.5%
138,205
-29.2%
0.00%
Q3 2014$217,000
-39.2%
195,097
+0.0%
0.00%
Q2 2014$357,000
+8.5%
195,051
-11.5%
0.00%
Q1 2014$329,000
-26.4%
220,384
-9.8%
0.00%
Q4 2013$447,000
+62.5%
244,448
+82.7%
0.00%
Q3 2013$275,000
+26.7%
133,790
+53.9%
0.00%
Q2 2013$217,000
-86.7%
86,935
-57.2%
0.00%
-100.0%
Q4 2012$1,635,000
-13.9%
203,160
+11.3%
0.00%0.0%
Q3 2012$1,899,000
-8.1%
182,481
+7.3%
0.00%0.0%
Q2 2012$2,067,000
-2.6%
169,991
-0.6%
0.00%0.0%
Q1 2012$2,122,000170,9380.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,866,483$4,285,0002.24%
Sarissa Capital Management LP 2,570,759$3,843,0001.32%
Greylock XI GP Limited Partnership 584,004$876,0000.56%
Deer VI & Co. LLC 675,242$1,013,0000.44%
DAFNA Capital Management LLC 261,507$391,0000.34%
Palo Alto Investors LP 2,858,348$4,274,0000.18%
Baupost Group 3,829,350$5,725,0000.14%
SABBY MANAGEMENT, LLC 573,416$857,0000.05%
Granahan Investment Management 676,451$1,011,0000.03%
TFS CAPITAL LLC 176,633$264,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders